Dianthus Therapeutics, Inc. /DE/

Ownership Transactions Reported by 30 Insiders

Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
300 Technology Square, 8 Th Floor, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Dianthus Therapeutics, Inc. /DE/ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lei Meng Director $54.6M Jan 22, 2024
Fairmount Funds Management LLC Director $42.4M Sep 27, 2024
Third Rock Ventures IV, L.P. 10%+ Owner $36.7M Feb 7, 2023
Leon O. Moulder Jr Director $17.2M May 23, 2024
Jason Gardner Title: President and Chief Executive Officer, Director $11.3M Nov 30, 2022
Kristen Stants Chief People Officer $243K Nov 30, 2022
Thomas Beetham Title: Chief Legal Officer and Secretary $239K Nov 30, 2022
Caren Deardorf Chief Commercial Officer $237K Nov 30, 2022
Stephen Mahoney Title: Chief Financial and Operating Officer $207K Nov 30, 2022
Alexis Borisy Director $49.2K Aug 26, 2021
Simrat Randhawa Chief Medical Officer $48K May 23, 2024
Ryan Savitz Cfo & Cbo May 23, 2024
Alison Frances Lawton Director May 23, 2024
Jonathan Violin Director May 23, 2024
Anne McGeorge Director May 23, 2024
Edward Carr Chief Accounting Officer May 23, 2024
Paula Soteropoulos Director May 23, 2024
M. Veness SVP, General Counsel and Sec. May 23, 2024
Marino Garcia CEO AND PRESIDENT, Director May 23, 2024
Steven J. Romano Director Sep 16, 2024
Michael Vasconcelles Director Aug 15, 2022
David Scadden Director Jun 28, 2022
Thomas O. Daniel Director Jun 28, 2022
Jeffrey Humphrey Chief Medical Officer Aug 1, 2022
Michael W. Bonney Director Jun 1, 2021
Lisa Olson Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney Aug 1, 2022
David Wayne Nichols Chief Technical Officer Aug 1, 2022
Amy L. Ronneberg Director Jun 28, 2022
Jeffrey W. Albers Director Jun 28, 2022
Bruce Booth Director Jun 28, 2022

Recent Insider Transactions by Companies or Individuals for Dianthus Therapeutics, Inc. /DE/

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.